Geoffrey C. Dunbar
2010
In 2010, Geoffrey C. Dunbar earned a total compensation of $1.1M as Senior Vice President, Clinical Development and Regulatory Affairs and Chief Medical Officer at Catalyst Biosciences, a 88% increase compared to previous year.
Compensation breakdown
| Bonus | $11,760 |
|---|---|
| Non-Equity Incentive Plan | $57,836 |
| Option Awards | $667,580 |
| Salary | $321,312 |
| Other | $9,800 |
| Total | $1,068,288 |
Dunbar received $667.6K in option awards, accounting for 62% of the total pay in 2010.
Dunbar also received $11.8K in bonus, $57.8K in non-equity incentive plan, $321.3K in salary and $9.8K in other compensation.
Rankings
In 2010, Geoffrey C. Dunbar's compensation ranked 5,052nd out of 10,439 executives tracked by ExecPay. In other words, Dunbar earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,052 out of 10,439 | 52nd |
Division Manufacturing | 1,818 out of 3,838 | 53rd |
Major group Chemicals And Allied Products | 376 out of 926 | 59th |
Industry group Drugs | 223 out of 685 | 67th |
Industry Pharmaceutical Preparations | 171 out of 481 | 64th |
Source: SEC filing on April 21, 2011.
Dunbar's colleagues
We found four more compensation records of executives who worked with Geoffrey C. Dunbar at Catalyst Biosciences in 2010.
2010
J deBethizy
Catalyst Biosciences
Chief Executive Officer
2010
Jeffrey Brennan
Catalyst Biosciences
Former Senior Vice President, Business and Commercial Development and Chief Business Officer
2010
Alan Musso
Catalyst Biosciences
Chief Financial Officer
2010
Peter Zorn
Catalyst Biosciences